Protein tyrosine phosphatases as emerging targets for cancer immunotherapy

作者：Zihan Qu, Jiajun Dong, Zhong‐Yin Zhang · 发表于：British Journal of Pharmacology · 年份：2023 · DOI：10.1111/bph.16304 · 被引用次数：10 · 研究领域：Protein Tyrosine Phosphatases、Galectins and Cancer Biology、Biochemical and Molecular Research

Contemporary strategies in cancer immunotherapy, despite remarkable success, remain constrained by inherent limitations such as suboptimal patient responses, the emergence of drug resistance, and the manifestation of pronounced adverse effects. Consequently, the need for alternative strategies for immunotherapy becomes clear. Protein tyrosine phosphatases (PTPs) wield a pivotal regulatory influence over an array of essential cellular processes. Substantial research has underscored the potential in targeting PTPs to modulate the immune responses and/or regulate antigen presentation, thereby presenting a novel paradigm for cancer immunotherapy. In this review, we focus on recent advances in genetic and biological validation of several PTPs as emerging targets for immunotherapy. We also highlight recent development of small molecule inhibitors and degraders targeting these PTPs as novel cancer immunotherapeutic agents. LINKED ARTICLES: This article is part of a themed issue Immunotherapy in Cancer. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v183.6/issuetoc.